These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 24437518)

  • 1. The ubiquitin-proteasome system in neurodegeneration.
    McKinnon C; Tabrizi SJ
    Antioxid Redox Signal; 2014 Dec; 21(17):2302-21. PubMed ID: 24437518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of ubiquitin proteasome system: risk for neurodegenerative diseases.
    Zheng C; Geetha T; Babu JR
    Neurodegener Dis; 2014; 14(4):161-75. PubMed ID: 25413678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Removing protein aggregates: the role of proteolysis in neurodegeneration.
    Nijholt DA; De Kimpe L; Elfrink HL; Hoozemans JJ; Scheper W
    Curr Med Chem; 2011; 18(16):2459-76. PubMed ID: 21568912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role for the ubiquitin-proteasome system in Parkinson's disease and other neurodegenerative brain amyloidoses.
    Moore DJ; Dawson VL; Dawson TM
    Neuromolecular Med; 2003; 4(1-2):95-108. PubMed ID: 14528055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin proteasome system as a pharmacological target in neurodegeneration.
    Hol EM; Fischer DF; Ovaa H; Scheper W
    Expert Rev Neurother; 2006 Sep; 6(9):1337-47. PubMed ID: 17009921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ubiquitin-proteasome system in retinal health and disease.
    Campello L; Esteve-Rudd J; Cuenca N; Martín-Nieto J
    Mol Neurobiol; 2013 Apr; 47(2):790-810. PubMed ID: 23339020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ubiquitin/proteasome pathway impairment in neurodegeneration: therapeutic implications.
    Huang Q; Figueiredo-Pereira ME
    Apoptosis; 2010 Nov; 15(11):1292-311. PubMed ID: 20131003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion-mediated neurodegeneration is associated with early impairment of the ubiquitin-proteasome system.
    McKinnon C; Goold R; Andre R; Devoy A; Ortega Z; Moonga J; Linehan JM; Brandner S; Lucas JJ; Collinge J; Tabrizi SJ
    Acta Neuropathol; 2016 Mar; 131(3):411-25. PubMed ID: 26646779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin biology in neurodegenerative disorders: From impairment to therapeutic strategies.
    Kumar D; Ambasta RK; Kumar P
    Ageing Res Rev; 2020 Aug; 61():101078. PubMed ID: 32407951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ubiquitin proteasome system in neurodegenerative diseases: culprit, accomplice or victim?
    Dennissen FJ; Kholod N; van Leeuwen FW
    Prog Neurobiol; 2012 Feb; 96(2):190-207. PubMed ID: 22270043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ubiquitin-proteasome system and neurodegenerative disorders.
    Layfield R; Lowe J; Bedford L
    Essays Biochem; 2005; 41():157-71. PubMed ID: 16250904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein clearance strategies for disease intervention.
    Hommen F; Bilican S; Vilchez D
    J Neural Transm (Vienna); 2022 Feb; 129(2):141-172. PubMed ID: 34689261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Ubiquitin-Proteasome Pathway by Natural Products: Novel Therapeutic Strategy for Treatment of Neurodegenerative Diseases.
    Momtaz S; Memariani Z; El-Senduny FF; Sanadgol N; Golab F; Katebi M; Abdolghaffari AH; Farzaei MH; Abdollahi M
    Front Physiol; 2020; 11():361. PubMed ID: 32411012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteostasis in neurodegenerative diseases.
    Kinger S; Jagtap YA; Kumar P; Choudhary A; Prasad A; Prajapati VK; Kumar A; Mehta G; Mishra A
    Adv Clin Chem; 2024; 121():270-333. PubMed ID: 38797543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential activities of the ubiquitin-proteasome system in neurons versus glia may account for the preferential accumulation of misfolded proteins in neurons.
    Tydlacka S; Wang CE; Wang X; Li S; Li XJ
    J Neurosci; 2008 Dec; 28(49):13285-95. PubMed ID: 19052220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ubiquitin proteasomal system: a potential target for the management of Alzheimer's disease.
    Gadhave K; Bolshette N; Ahire A; Pardeshi R; Thakur K; Trandafir C; Istrate A; Ahmed S; Lahkar M; Muresanu DF; Balea M
    J Cell Mol Med; 2016 Jul; 20(7):1392-407. PubMed ID: 27028664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ubiquitin proteasome system as a potential target for the treatment of neurodegenerative diseases.
    Ying Z; Wang H; Wang G
    Curr Pharm Des; 2013; 19(18):3305-14. PubMed ID: 23151138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?
    Matsuda N; Tanaka K
    J Alzheimers Dis; 2010; 19(1):1-9. PubMed ID: 20061621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
    Ciechanover A; Kwon YT
    Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuronal ubiquitin-proteasome system: murine models and their neurological phenotype.
    van Tijn P; Hol EM; van Leeuwen FW; Fischer DF
    Prog Neurobiol; 2008 Jun; 85(2):176-93. PubMed ID: 18448229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.